There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.
The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers.
The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life.
The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.
By developing a therapy which is safe and effective we hope to set a better future for patients in need.
02.10.2025
Life sciences companies make positive progress (startupticker.ch)
29.08.2024
Remarkable milestones for three life sciences start-ups (startupticker.ch)
11.09.2023
Home market success triggers Piomic’s expansion into the US (startupticker.ch)
16.03.2023
New leadership and the next generation in various Swiss startups (startupticker.ch)
01.12.2022
Piomic Medical receives green light for U.S. pivotal trial (startupticker.ch)
No Jobs
Piomic Medical - Patient Testimonials COMS® Therapy - Improving Access to Standard of Care
COMS® Mechanism of Action
COMS® One Product Application
Company Movie 2020
W.A. de Vigier Startup Award 2019
No Awards
Website:
www.piomic.com
Headquarter:
Zürich
Foundation Date:
June 2016
Technology:
Sectors: